AI Drug Discovery
Sep 24, 2026 · 1 min read · 45,882 views
A federal AI experiment could transform chronic care - if doctors and patients want it
S
Sophia Reyes
Editorial · Sep 24, 2026
A new government program that will push the boundaries of AI in medicine could transform how the US cares for patients with heart failure and eventually other chronic diseases. But that's only if the public's
← Previous
Updated: Ultragenyx's new gene therapy will cost $3.95M
Next →
Telix and radioisotope maker ITM merge in deal worth up to $2.35B
Related Reading
AI Drug Discovery
After years of hype, the first AI-designed drugs fall short in the clinic
Sep 27, 2026
AI Drug Discovery
Nvidia-backed Iambic files for IPO, disclosing new clinic and dealmaking details
Sep 09, 2026
Industry Insights
Post-Hoc Live: How much is everyone in biopharma getting paid?
Sep 28, 2026